Explore
Validate
Learn14154-1-AP
antibody from Proteintech Group
Targeting: LILRB2
CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14154-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- LILRB2 antibody
- Antibody type
- Polyclonal
- Description
- LILRB2 antibody (Cat. #14154-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A novel risk model incorporating MMP9, TLR8, and LILRB2 drives neutrophil extracellular trap formation and promotes immune evasion in glioma.
Leukocyte immunoglobulin-like receptor B2 regulates atherosclerosis progression by modulating macrophage extracellular trap formation in foam macrophages through the PI3K-AKT signaling pathway.
Luan Y, Fang J, Li J, Chen X, Li J, Pennisi R, Huang L, Kalamvoki M, Sciortino MT, Meng Y, Wang Y, Shu M
International immunopharmacology 2026 Apr 15;175:116403
International immunopharmacology 2026 Apr 15;175:116403
Leukocyte immunoglobulin-like receptor B2 regulates atherosclerosis progression by modulating macrophage extracellular trap formation in foam macrophages through the PI3K-AKT signaling pathway.
Jiao Y, Hu R, Gui L, Miu S, Zhang X, Zou J
Journal of cell communication and signaling 2025 Dec;19(4):e70053
Journal of cell communication and signaling 2025 Dec;19(4):e70053
No comments: Submit comment
No validations: Submit validation data